Thomas A. Waldmann

62.9k total citations · 19 hit papers
580 papers, 47.6k citations indexed

About

Thomas A. Waldmann is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Thomas A. Waldmann has authored 580 papers receiving a total of 47.6k indexed citations (citations by other indexed papers that have themselves been cited), including 382 papers in Immunology, 118 papers in Oncology and 97 papers in Molecular Biology. Recurrent topics in Thomas A. Waldmann's work include Immune Cell Function and Interaction (193 papers), T-cell and Retrovirus Studies (146 papers) and Monoclonal and Polyclonal Antibodies Research (90 papers). Thomas A. Waldmann is often cited by papers focused on Immune Cell Function and Interaction (193 papers), T-cell and Retrovirus Studies (146 papers) and Monoclonal and Polyclonal Antibodies Research (90 papers). Thomas A. Waldmann collaborates with scholars based in United States, Germany and Japan. Thomas A. Waldmann's co-authors include Yutaka Tagaya, Warren Strober, Stanley J. Korsmeyer, S Broder, Warner C. Greene, Warren J. Leonard, Takashi Uchiyama, Philip Leder, Sigrid Dubois and Richard N. Bamford and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Thomas A. Waldmann

575 papers receiving 44.3k citations

Hit Papers

A monoclonal antibody (anti-Tac) reactive with activated ... 1961 2026 1982 2004 1981 2006 1981 2005 2002 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.
    1981 1.2k citations Thomas A. Waldmann et al. profile →
  2. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
    2006 903 citations Thomas A. Waldmann profile →
  3. Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes
    1981 856 citations Thomas A. Waldmann et al. profile →
  4. Central memory self/tumor-reactive CD8 + T cells confer superior antitumor immunity compared with effector memory T cells
    2005 752 citations Christopher A. Klebanoff, Luca Gattinoni et al. Proceedings of the National Academy of Sciences profile →
  5. IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
    2002 737 citations Sigrid Dubois, Jennifer Mariner et al. profile →
  6. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor
    1984 734 citations Thomas A. Waldmann et al. profile →
  7. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor
    1982 731 citations Thomas A. Waldmann et al. profile →
  8. Qualitative Analysis of Immune Function in Patients with the Acquired Immunodeficiency Syndrome
    1985 614 citations Thomas A. Waldmann et al. profile →
  9. ROLE OF SUPPRESSOR T CELLS IN PATHOGENESIS OF COMMON VARIABLE HYPOGAMMAGLOBULINÆMIA
    1974 594 citations Thomas A. Waldmann et al. profile →
  10. THE MULTIFACETED REGULATION OF INTERLEUKIN-15 EXPRESSION AND THE ROLE OF THIS CYTOKINE IN NK CELL DIFFERENTIATION AND HOST RESPONSE TO INTRACELLULAR PATHOGENS
    1999 587 citations Thomas A. Waldmann, Yutaka Tagaya profile →
  11. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.
    1984 517 citations Thomas A. Waldmann et al. Proceedings of the National Academy of Sciences profile →
  12. Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid Neoplasms
    1983 514 citations Elaine S. Jaffe, Thomas A. Waldmann et al. profile →
  13. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins.
    1983 495 citations Thomas A. Waldmann et al. profile →
  14. Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells.
    1981 465 citations Thomas A. Waldmann et al. Proceedings of the National Academy of Sciences profile →
  15. Expression of interleukin 2 receptors on activated human B cells.
    1984 425 citations Thomas A. Waldmann et al. profile →
  16. Metabolic properties of IgG subclasses in man
    1970 402 citations Thomas A. Waldmann et al. profile →
  17. Cytokines in the Treatment of Cancer
    2018 362 citations Kevin C. Conlon, Miloš D. Miljković et al. profile →
  18. Protein-losing enteropathy
    1966 294 citations Thomas A. Waldmann profile →
  19. The Role of the Gastrointestinal System in “Idiopathic Hypoproteinemia”
    1961 274 citations Thomas A. Waldmann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas A. Waldmann United States 115 27.9k 10.7k 10.4k 6.7k 4.9k 580 47.6k
Thomas F. Tedder United States 113 26.9k 1.0× 7.0k 0.7× 8.0k 0.8× 5.3k 0.8× 4.8k 1.0× 342 41.1k
Herman Waldmann United Kingdom 105 22.3k 0.8× 5.4k 0.5× 6.9k 0.7× 6.3k 0.9× 3.3k 0.7× 539 36.5k
Eugene C. Butcher United States 126 31.9k 1.1× 10.2k 1.0× 12.4k 1.2× 4.9k 0.7× 2.1k 0.4× 338 53.4k
Jacques Banchereau United States 132 62.4k 2.2× 15.0k 1.4× 16.4k 1.6× 4.8k 0.7× 3.3k 0.7× 477 80.5k
Tasuku Honjo Japan 129 39.3k 1.4× 23.2k 2.2× 24.8k 2.4× 6.4k 1.0× 3.3k 0.7× 582 72.1k
Klaus Rajewsky Germany 145 41.7k 1.5× 11.3k 1.1× 30.1k 2.9× 11.3k 1.7× 8.5k 1.7× 505 77.2k
Wolf H. Fridman France 100 31.2k 1.1× 27.6k 2.6× 16.6k 1.6× 6.3k 0.9× 3.4k 0.7× 529 57.4k
Stuart F. Schlossman United States 99 22.1k 0.8× 6.4k 0.6× 8.2k 0.8× 10.3k 1.5× 3.1k 0.6× 338 35.6k
Lorenzo Moretta Italy 128 48.3k 1.7× 14.2k 1.3× 7.5k 0.7× 3.3k 0.5× 1.8k 0.4× 678 60.8k
Ronald Levy United States 109 20.4k 0.7× 14.4k 1.3× 11.4k 1.1× 11.8k 1.8× 12.8k 2.6× 694 44.9k

Countries citing papers authored by Thomas A. Waldmann

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Waldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Waldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Waldmann more than expected).

Fields of papers citing papers by Thomas A. Waldmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Waldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Waldmann. The network helps show where Thomas A. Waldmann may publish in the future.

Co-authorship network of co-authors of Thomas A. Waldmann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Waldmann. A scholar is included among the top collaborators of Thomas A. Waldmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Waldmann. Thomas A. Waldmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Li, Nguyet M. Hoang, Fen Zhu, et al.. (2021). EGR1 Addiction in Diffuse Large B-cell Lymphoma. Molecular Cancer Research. 19(8). 1258–1269. 10 indexed citations
2.
Wei, Wei, Zhihui Song, Wenming Xiao, et al.. (2020). A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models. Clinical Cancer Research. 26(15). 4093–4106. 20 indexed citations
3.
Song, Zhihui, Wei Wei, Wenming Xiao, et al.. (2020). Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma. Proceedings of the National Academy of Sciences. 117(46). 28980–28991. 17 indexed citations
4.
Conlon, Kevin C., E. Lake Potter, Stefania Pittaluga, et al.. (2019). IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion. Clinical Cancer Research. 25(16). 4945–4954. 95 indexed citations
5.
Dubois, Sigrid, et al.. (2017). IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities. Cancer Immunology Research. 5(10). 929–938. 61 indexed citations
6.
Sharma, Kamal, John E. Janik, Deirdre O’Mahony, et al.. (2016). Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1–Associated Adult T-cell Leukemia/lymphoma. Clinical Cancer Research. 23(1). 35–42. 36 indexed citations
7.
Waldmann, Thomas A.. (2015). The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy. Cancer Immunology Research. 3(3). 219–227. 170 indexed citations
8.
9.
Yu, Ping, Jason C. Steel, Meili Zhang, John C. Morris, & Thomas A. Waldmann. (2010). Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model. Clinical Cancer Research. 16(24). 6019–6028. 172 indexed citations
10.
Pancewicz, Joanna, John M. Taylor, Abhik Datta, et al.. (2010). Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1–associated adult T-cell leukemia. Proceedings of the National Academy of Sciences. 107(38). 16619–16624. 77 indexed citations
11.
O’Mahony, Deirdre, John C. Morris, Maryalice Stetler‐Stevenson, et al.. (2009). EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies. Clinical Cancer Research. 15(7). 2514–2522. 35 indexed citations
12.
Robinson, Matthew K., Calvin Shaller, Kayhan Garmestani, et al.. (2008). Effective Treatment of Established Human Breast Tumor Xenografts in Immunodeficient Mice with a Single Dose of the α-Emitting Radioisotope Astatine-211 Conjugated to Anti-HER2/neu Diabodies. Clinical Cancer Research. 14(3). 875–882. 47 indexed citations
13.
Bielekova, Bibiana, Marta Catálfamo, Nicolle H. Packer, et al.. (2006). Regulatory CD56 bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proceedings of the National Academy of Sciences. 103(15). 5941–5946. 465 indexed citations
14.
Wani, Manzoor A., Lynn D. Haynes, Jong‐Han Kim, et al.. (2006). Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant β 2 -microglobulin gene. Proceedings of the National Academy of Sciences. 103(13). 5084–5089. 108 indexed citations
15.
Klebanoff, Christopher A., Steven E. Finkelstein, Deborah R. Surman, et al.. (2004). IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8 + T Cells. Proceedings of the National Academy of Sciences. 101(7). 1969–1974. 481 indexed citations
16.
Oh, SangKon, Liyanage P. Perera, Donald S. Burke, Thomas A. Waldmann, & Jay A. Berzofsky. (2004). IL-15/IL-15Rα-mediated avidity maturation of memory CD8 + T cells. Proceedings of the National Academy of Sciences. 101(42). 15154–15159. 110 indexed citations
17.
Azimi, Nazli, Jennifer Mariner, Steven Jacobson, & Thomas A. Waldmann. (2000). How Does Interleukin 15 Contribute to the Pathogenesis of HTLV Type 1-Associated Myelopathy/Tropical Spastic Paraparesis?. AIDS Research and Human Retroviruses. 16(16). 1717–1722. 17 indexed citations
18.
Gupta, Sudhir, et al.. (1992). Mechanisms of lymphocyte activation and immune regulation IV : cellular communications. Plenum Press eBooks. 10 indexed citations
19.
Greenberg, Steven J., Steven Jacobson, Thomas A. Waldmann, & D. E. McFarlin. (1989). Molecular Analysis of HTLV-I Proviral Integration and T Cell Receptor Arrangement Indicates That T Cells in Tropical Spastic Paraparesis Are Polyclonal. The Journal of Infectious Diseases. 159(4). 741–744. 28 indexed citations
20.
Kozak, Robert W., Joyce F. Haskell, Lawrence A. Greenstein, et al.. (1987). Type I and II insulin-like growth factor receptors on human phytohemagglutinin-activated T lymphocytes. Cellular Immunology. 109(2). 318–331. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas F. Tedder Breakdown of academic impact, for papers by Herman Waldmann Breakdown of academic impact, for papers by Eugene C. Butcher Breakdown of academic impact, for papers by Jacques Banchereau Breakdown of academic impact, for papers by Tasuku Honjo Breakdown of academic impact, for papers by Klaus Rajewsky Breakdown of academic impact, for papers by Wolf H. Fridman Breakdown of academic impact, for papers by Stuart F. Schlossman Breakdown of academic impact, for papers by Lorenzo Moretta Breakdown of academic impact, for papers by Ronald Levy
Rankless by CCL
2026